Topic: In the Pipe: Treatment, management of IBM
- Novartis' Bimagrumab receives FDA breakthrough therapy designation for sporadic Inclusion Body Myositis (sIBM) - ITNews
- Novartis receives US breakthrough designation for BYM338 - Zenopa
Topic: Life Stories
- Hillsboro boy's life remembered after battling Juvenile Myositis for ... - OregonLive.com
- Alderfer Family Recognized As Cure JM Foundation Heroes - Stacey Page Online